Medeze

On valuation, the picture is expensive. The owner-earnings multiple stands at 117.8×; owner earnings: the cash an owner could take out each year. The implied growth embedded in that price is around 30% a year, against analyst forecasts of 33%. The price, in other words, assumes less than the experts do.

Growth is solid; the safety picture is sturdy. The company scores 6/20 on our value-creation score: not creating value. Analysts lean positive.

Flags to be aware of: Reported profits have run ahead of actual cash for several periods. As always: this describes the company's numbers; it is not a recommendation.